Eagle Pharmaceuticals Ownership 2024 | Who Owns Eagle Pharmaceuticals Now?
Institutional Ownership
75.40%
Insider Ownership
12.02%
Retail Ownership
12.58%
Institutional Holders
76.00
Eagle Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL MANAGEMENT, LLC | 14.99% | 0.65% | 1,962,070 | 703,308 | 55.87% | 10,987,592 | Jun 30, 2024 |
| AIGH CAPITAL MANAGEMENT LLC | 9.25% | 2.11% | 1,211,509 | 25,000 | 2.11% | 6,784,451 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 7.64% | 0.33% | 1,000,000 | 1,000,000 | 100.00% | 5,600,000 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 5.32% | 0.01% | 696,797 | -182,276 | -20.73% | 3,902,063 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.31% | 0.00% | 564,396 | -76,358 | -11.92% | 3,160,617 | Jun 30, 2024 |
| BLACKROCK INC. | 2.69% | - | 352,762 | -545,044 | -60.71% | 1,975,466 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 2.49% | 0.00% | 325,519 | 15 | 0.00% | 1,822,906 | Jun 30, 2024 |
| MORGAN STANLEY | 2.30% | 0.00% | 300,448 | -74,881 | -19.95% | 1,682,509 | Jun 30, 2024 |
| LSV ASSET MANAGEMENT | 2.26% | 0.00% | 295,388 | -38,770 | -11.60% | 1,654,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.87% | 0.00% | 244,250 | -89,600 | -26.84% | 1,367,800 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.49% | 0.00% | 195,475 | -61,994 | -24.08% | 1,094,660 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 1.46% | 0.03% | 191,111 | -67,585 | -26.13% | 1,070,222 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 1.42% | 0.00% | 185,337 | - | - | 1,037,887 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.32% | 0.02% | 173,365 | 173,365 | 100.00% | 970,844 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.31% | 0.00% | 171,008 | -48,803 | -22.20% | 957,645 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.28% | 0.00% | 167,782 | -90,082 | -34.93% | 939,579 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.02% | 0.00% | 133,944 | -29,491 | -18.04% | 750,086 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 1.01% | 0.00% | 132,606 | -59,126 | -30.84% | 742,594 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.98% | 0.04% | 128,087 | 128,087 | 100.00% | 717,287 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.91% | 0.07% | 118,857 | - | - | 665,599 | Jun 30, 2024 |
Eagle Pharmaceuticals's largest institutional shareholder is NANTAHALA CAPITAL MANAGEMENT, LLC, holding 14.99% of the company's total share outstanding, currently valued at $10.99M. The top 10 institutional shareholders own together 53.11% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AIGH CAPITAL MANAGEMENT LLC | 9.25% | 2.11% | 1,211,509 | 25,000 | 2.11% | 6,784,451 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 14.99% | 0.65% | 1,962,070 | 703,308 | 55.87% | 10,987,592 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 7.64% | 0.33% | 1,000,000 | 1,000,000 | 100.00% | 5,600,000 | Jun 30, 2024 |
| AJOVISTA, LLC | 0.09% | 0.18% | 11,232 | - | - | 62,899 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.91% | 0.07% | 118,857 | - | - | 665,599 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.98% | 0.04% | 128,087 | 128,087 | 100.00% | 717,287 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 1.46% | 0.03% | 191,111 | -67,585 | -26.13% | 1,070,222 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.17% | 0.02% | 22,000 | 22,000 | 100.00% | 123,200 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.32% | 0.02% | 173,365 | 173,365 | 100.00% | 970,844 | Jun 30, 2024 |
| WEALTHCOLLAB, LLC | 0.03% | 0.02% | 4,375 | -911 | -17.23% | 24,500 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.23% | 0.02% | 30,011 | 2,953 | 10.91% | 168,062 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.01% | 11,612 | 11,612 | 100.00% | 65,028 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.15% | 0.01% | 20,204 | 20,204 | 100.00% | 113,142 | Jun 30, 2024 |
| STANLEY-LAMAN GROUP, LTD. | 0.09% | 0.01% | 12,000 | - | - | 67,200 | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | 0.10% | 0.01% | 12,762 | 12,762 | 100.00% | 54,239 | Jun 30, 2024 |
| STATE OF WYOMING | 0.06% | 0.01% | 8,118 | -13,531 | -62.50% | 45,461 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 5.32% | 0.01% | 696,797 | -182,276 | -20.73% | 3,902,063 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.40% | 0.00% | 52,953 | -36,489 | -40.80% | 296,537 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.24% | 0.00% | 31,900 | - | - | 178,640 | Jun 30, 2024 |
| LSV ASSET MANAGEMENT | 2.26% | 0.00% | 295,388 | -38,770 | -11.60% | 1,654,000 | Jun 30, 2024 |
The largest Eagle Pharmaceuticals shareholder by % of total assets is AIGH CAPITAL MANAGEMENT LLC. The company owns 1.21M shares of Eagle Pharmaceuticals (EGRX), representing 2.11% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL MANAGEMENT, LLC | 7.64% | 0.33% | 1,000,000 | 1,000,000 | 100.00% | 5,600,000 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 14.99% | 0.65% | 1,962,070 | 703,308 | 55.87% | 10,987,592 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.32% | 0.02% | 173,365 | 173,365 | 100.00% | 970,844 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.98% | 0.04% | 128,087 | 128,087 | 100.00% | 717,287 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.20% | 0.00% | 25,812 | 25,812 | 100.00% | 144,546 | Jun 30, 2024 |
| AIGH CAPITAL MANAGEMENT LLC | 9.25% | 2.11% | 1,211,509 | 25,000 | 2.11% | 6,784,451 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.17% | 0.02% | 22,000 | 22,000 | 100.00% | 123,200 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.15% | 0.01% | 20,204 | 20,204 | 100.00% | 113,142 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.14% | 0.00% | 17,825 | 17,825 | 100.00% | 99,820 | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 0.10% | 0.00% | 13,629 | 13,629 | 100.00% | 76,322 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.13% | 0.00% | 16,763 | 13,212 | 372.06% | 93,872 | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | 0.10% | 0.01% | 12,762 | 12,762 | 100.00% | 54,239 | Jun 30, 2024 |
| GREAT LAKES ADVISORS, LLC | 0.18% | 0.00% | 23,622 | 12,275 | 108.18% | 132,283 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.01% | 11,612 | 11,612 | 100.00% | 65,028 | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | 0.08% | 0.00% | 10,786 | 10,786 | 100.00% | 60,402 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.29% | - | 37,601 | 9,445 | 33.55% | 211,000 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.07% | 0.00% | 9,798 | 7,486 | 323.79% | 54,868 | Jun 30, 2024 |
| FMR LLC | 0.22% | - | 29,163 | 7,060 | 31.94% | 163,313 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 4,881 | 4,881 | 100.00% | 27,334 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.23% | 0.02% | 30,011 | 2,953 | 10.91% | 168,062 | Jun 30, 2024 |
As of Jun 30 2024, Eagle Pharmaceuticals's largest institutional buyer is NANTAHALA CAPITAL MANAGEMENT, LLC. The company purchased 1.00M stocks of EGRX, valued at $5.60M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 2.69% | - | 352,762 | -545,044 | -60.71% | 1,975,466 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 5.32% | 0.01% | 696,797 | -182,276 | -20.73% | 3,902,063 | Jun 30, 2024 |
| STATE STREET CORP | 0.27% | - | 35,820 | -177,847 | -83.24% | 200,592,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -171,091 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.82% | 0.00% | 108,004 | -123,637 | -53.37% | 604,976 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -123,002 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -105,221 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.60% | 0.00% | 79,093 | -98,714 | -55.52% | 442,921 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.28% | 0.00% | 167,782 | -90,082 | -34.93% | 939,579 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.87% | 0.00% | 244,250 | -89,600 | -26.84% | 1,367,800 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.31% | 0.00% | 564,396 | -76,358 | -11.92% | 3,160,617 | Jun 30, 2024 |
| MORGAN STANLEY | 2.30% | 0.00% | 300,448 | -74,881 | -19.95% | 1,682,509 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 1.46% | 0.03% | 191,111 | -67,585 | -26.13% | 1,070,222 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.49% | 0.00% | 195,475 | -61,994 | -24.08% | 1,094,660 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 1.01% | 0.00% | 132,606 | -59,126 | -30.84% | 742,594 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.02% | - | 2,317 | -56,314 | -96.05% | 12,975 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | - | - | - | -55,748 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.31% | 0.00% | 171,008 | -48,803 | -22.20% | 957,645 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -42,118 | -100.00% | - | Jun 30, 2024 |
| LSV ASSET MANAGEMENT | 2.26% | 0.00% | 295,388 | -38,770 | -11.60% | 1,654,000 | Jun 30, 2024 |
As of Jun 30 2024, Eagle Pharmaceuticals's biggest institutional seller is BLACKROCK INC.. The company sold -0.55M shares of EGRX, valued at $1.98M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL MANAGEMENT, LLC | 7.64% | 0.33% | 1,000,000 | 1,000,000 | 100.00% | 5,600,000 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.32% | 0.02% | 173,365 | 173,365 | 100.00% | 970,844 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.98% | 0.04% | 128,087 | 128,087 | 100.00% | 717,287 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.17% | 0.02% | 22,000 | 22,000 | 100.00% | 123,200 | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 0.10% | 0.00% | 13,629 | 13,629 | 100.00% | 76,322 | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | 0.10% | 0.01% | 12,762 | 12,762 | 100.00% | 54,239 | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | 0.08% | 0.00% | 10,786 | 10,786 | 100.00% | 60,402 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 4,881 | 4,881 | 100.00% | 27,334 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 518 | 518 | 100.00% | 2,901 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | - | 49 | 49 | 100.00% | 274 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 28 | 28 | 100.00% | 157 | Jun 30, 2024 |
Eagle Pharmaceuticals's largest new institutional shareholder by number of shares is NANTAHALA CAPITAL MANAGEMENT, LLC, purchased 1.00M shares, valued at $5.60M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -171,091 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -123,002 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -105,221 | -100.00% | - | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | - | - | - | -55,748 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -42,118 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -35,287 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -26,600 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -21,390 | -100.00% | - | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -19,373 | -100.00% | - | Jun 30, 2024 |
| SAVANT CAPITAL, LLC | - | - | - | -16,654 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -10,215 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -8,700 | -100.00% | - | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -6,641 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -5,099 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -1,830 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -1,679 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -1,200 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -1,040 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -867 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -819 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -394 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -285 | -100.00% | - | Jun 30, 2024 |
| MASSMUTUAL TRUST CO FSB/ADV | - | - | - | -170 | -100.00% | - | Jun 30, 2024 |
| FORTITUDE FAMILY OFFICE, LLC | - | - | - | -117 | -100.00% | - | Jun 30, 2024 |
| BARRETT & COMPANY, INC. | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| NORDWAND ADVISORS, LLC | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
Eagle Pharmaceuticals's largest sold out institutional shareholder by shares sold is DIMENSIONAL FUND ADVISORS LP, sold -0.17M shares, valued at -, as of undefined.
Eagle Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| EntrepreneurShares Series Trust | 0.09% | 25,136 | - | - | Dec 31, 2023 |
| ROYCE VALUE TRUST, INC. | 0.06% | 46,586 | - | - | Mar 31, 2024 |
| SARATOGA ADVANTAGE TRUST | 0.04% | 2,585 | - | - | Feb 29, 2024 |
| SYNTAX ETF TRUST | 0.04% | 1,243 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.03% | 67,064 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 9,445 | - | - | Mar 31, 2024 |
| OAK ASSOCIATES FUNDS | 0.02% | 17,105 | - | - | Jan 31, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.01% | 63,862 | - | - | Feb 29, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.01% | 14,328 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.01% | 30,000 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY GROWTH FUNDS, INC. | 0.01% | 1,821 | - | - | Jan 31, 2024 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.01% | 5,987 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.01% | 7,041 | - | - | Mar 31, 2024 |
| Legg Mason ETF Investment Trust | 0.01% | 13,821 | 9,859 | 248.84% | Mar 31, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.01% | 33,045 | - | - | Feb 29, 2024 |
| Humankind Benefit Corp | 0.01% | 129 | - | - | Dec 31, 2023 |
| IndexIQ ETF Trust | 0.01% | 11,534 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.00% | 11,537 | - | - | Mar 31, 2024 |
| Lattice Strategies Trust | 0.00% | 5,342 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.00% | 3,484 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 17,753 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 2,359 | - | - | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 28,091 | - | - | Mar 31, 2024 |
| TARGET PORTFOLIO TRUST | 0.00% | 55,100 | - | - | Jan 31, 2024 |
| Bernstein Fund Inc | 0.00% | 22,532 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,464 | - | - | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 728,207 | -344,565 | -32.12% | Dec 31, 2023 |
| Columbia Funds Variable Series Trust II | 0.00% | 67,505 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 11,827 | 5,600 | 89.93% | Aug 31, 2023 |
| GPS Funds I | 0.00% | 8,896 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 4,619 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 323 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 5,968 | - | - | Mar 31, 2024 |
| Chartwell Funds | 0.00% | 31,140 | - | - | Jun 30, 2022 |
| JNL VARIABLE FUND LLC | 0.00% | 7,755 | - | - | Mar 31, 2020 |
| Pacer Funds Trust | 0.00% | 64,040 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 487,684 | -150,918 | -23.63% | Mar 31, 2024 |
| ROYCE FUND | 0.00% | 7,362 | - | - | Mar 31, 2024 |
| CARILLON SERIES TRUST | 0.00% | 61,161 | - | - | Mar 31, 2024 |
| BRANDES INVESTMENT TRUST | 0.00% | 14,582 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 118,571 | 15,642 | 15.20% | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 22,200 | - | - | Jan 31, 2024 |
| SSGA FUNDS | 0.00% | 395 | - | - | Feb 29, 2024 |
| JAMES ADVANTAGE FUNDS | 0.00% | 1,650 | - | - | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 48,108 | - | - | Feb 29, 2024 |
| ALPS ETF Trust | 0.00% | 8,393 | - | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 11,691 | -136 | -1.15% | Mar 31, 2024 |
| Virtus Investment Trust | 0.00% | 20,867 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 7,338 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 23,660 | -30,314 | -56.16% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,494 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 98,917 | 4,689 | 4.98% | Feb 29, 2024 |
| PRAXIS MUTUAL FUNDS | 0.00% | 4,970 | - | - | Dec 31, 2023 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 89,733 | - | - | Mar 31, 2024 |
| TIMOTHY PLAN | 0.00% | 2,034 | - | - | Mar 31, 2024 |
| SHELTON FUNDS | 0.00% | 724 | - | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 3,081 | - | - | Jan 31, 2024 |
| Victory Portfolios II | 0.00% | 20,491 | - | - | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 6,404 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 867 | - | - | Mar 31, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 770 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 45,821 | - | - | Jan 31, 2024 |
| BMO FUNDS, INC. | 0.00% | 11,195 | -1,235 | -9.94% | Nov 30, 2021 |
| Dunham Funds | 0.00% | 17,073 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 7,396 | - | - | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 1,045 | - | - | Dec 31, 2023 |
| RBC FUNDS TRUST | 0.00% | 27,900 | 25,600 | 1113.04% | Mar 28, 2024 |
| UNIFIED SERIES TRUST | 0.00% | 3,600 | - | - | Mar 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 158 | - | - | Sep 30, 2023 |
| Cavanal Hill Funds | 0.00% | 450 | - | - | Feb 29, 2024 |
| Catholic Responsible Investments Funds | 0.00% | 7,381 | -538 | -6.79% | Jan 31, 2023 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 1,000 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 4,065 | - | - | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 5,769 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 90 | - | - | Apr 30, 2021 |
| Ultimus Managers Trust | 0.00% | 1,889 | - | - | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 40,438 | 208 | 0.52% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 71,024 | -4,126 | -5.49% | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 12,754 | 12 | 0.09% | Jan 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 31,366 | 1,287 | 4.28% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 4,310 | - | - | Mar 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 16,572 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 607 | - | - | Mar 31, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 9,150 | - | - | Mar 28, 2024 |
| FundVantage Trust | 0.00% | 1,755 | - | - | Mar 28, 2024 |
| Global X Funds | 0.00% | 4,884 | - | - | Jan 31, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 4,130 | - | - | Mar 31, 2024 |
| Guggenheim Variable Funds Trust | 0.00% | 410 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 101,585 | 591 | 0.59% | Jan 31, 2024 |
| Horizon Funds | 0.00% | 191 | - | - | Feb 29, 2024 |
| KP Funds | 0.00% | 4,257 | 600 | 16.41% | Sep 30, 2020 |
| THRIVENT SERIES FUND INC | 0.00% | 10,319 | - | - | Mar 28, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 50,155 | -3,551 | -6.61% | Feb 29, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 780 | - | - | Mar 28, 2024 |
| JPMORGAN TRUST II | 0.00% | 81,500 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 27,902 | -6,917 | -19.87% | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 6,377 | -3,528 | -35.62% | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 4,833 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 8,190 | -1,465 | -15.17% | Mar 28, 2024 |
| Trust for Advised Portfolios | 0.00% | 1,096 | - | - | Dec 31, 2023 |
Eagle Pharmaceuticals's largest mutual fund holder by % of total assets is "EntrepreneurShares Series Trust", owning 25.14K shares, compromising 0.09% of its total assets.
Eagle Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 76 | -18.28% |
| 31 Mar, 24 | 93 | -12.26% |
| 31 Dec, 23 | 106 | -2.75% |
| 30 Sep, 23 | 109 | -13.49% |
| 30 Jun, 23 | 126 | -18.71% |
| 31 Mar, 23 | 155 | - |
| 31 Dec, 22 | 155 | 2.65% |
| 30 Sep, 22 | 151 | -6.79% |
| 30 Jun, 22 | 162 | 0.62% |
| 31 Mar, 22 | 161 | -1.83% |
| 31 Dec, 21 | 164 | 6.49% |
| 30 Sep, 21 | 154 | 6.94% |
| 30 Jun, 21 | 144 | -6.49% |
| 31 Mar, 21 | 154 | -4.94% |
| 31 Dec, 20 | 162 | -4.14% |
| 30 Sep, 20 | 169 | 4.32% |
| 30 Jun, 20 | 162 | -4.14% |
| 31 Mar, 20 | 169 | -7.65% |
| 31 Dec, 19 | 183 | -2.14% |
| 30 Sep, 19 | 187 | 0.54% |
| 30 Jun, 19 | 186 | -2.11% |
| 31 Mar, 19 | 190 | 2.15% |
| 31 Dec, 18 | 186 | -5.58% |
| 30 Sep, 18 | 197 | 3.68% |
| 30 Jun, 18 | 190 | 5.56% |
| 31 Mar, 18 | 180 | 0.56% |
| 31 Dec, 17 | 179 | -1.65% |
| 30 Sep, 17 | 182 | -0.55% |
| 30 Jun, 17 | 183 | 18.83% |
| 31 Mar, 17 | 154 | -3.14% |
| 31 Dec, 16 | 159 | 6.00% |
| 30 Sep, 16 | 150 | 14.50% |
| 30 Jun, 16 | 131 | -3.68% |
| 31 Mar, 16 | 136 | -5.56% |
| 31 Dec, 15 | 144 | 13.39% |
| 30 Sep, 15 | 127 | 3.25% |
| 30 Jun, 15 | 123 | 80.88% |
| 31 Mar, 15 | 68 | 142.86% |
| 31 Dec, 14 | 28 | 7.69% |
| 30 Sep, 14 | 26 | -7.14% |
| 30 Jun, 14 | 28 | - |
| 31 Mar, 14 | 28 | - |
As of 30 Jun 24, 76 institutions are holding Eagle Pharmaceuticals's shares, representing a decrease of -18.28% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 9,870,425 | -5.60% |
| 31 Mar, 24 | 10,455,770 | 4.33% |
| 31 Dec, 23 | 10,021,957 | -3.36% |
| 30 Sep, 23 | 10,370,529 | -3.75% |
| 30 Jun, 23 | 10,774,946 | -8.55% |
| 31 Mar, 23 | 11,782,592 | 1.94% |
| 31 Dec, 22 | 11,558,213 | 0.59% |
| 30 Sep, 22 | 11,489,984 | -1.02% |
| 30 Jun, 22 | 11,608,832 | 3.48% |
| 31 Mar, 22 | 11,218,296 | -0.39% |
| 31 Dec, 21 | 11,262,332 | -4.78% |
| 30 Sep, 21 | 11,827,798 | -1.84% |
| 30 Jun, 21 | 12,049,528 | -1.09% |
| 31 Mar, 21 | 12,182,835 | -1.03% |
| 31 Dec, 20 | 12,309,266 | -1.56% |
| 30 Sep, 20 | 12,504,305 | -3.59% |
| 30 Jun, 20 | 12,969,419 | -2.31% |
| 31 Mar, 20 | 13,275,943 | 0.33% |
| 31 Dec, 19 | 13,231,987 | 0.38% |
| 30 Sep, 19 | 13,181,490 | -2.47% |
| 30 Jun, 19 | 13,515,159 | 0.84% |
| 31 Mar, 19 | 13,403,180 | -4.51% |
| 31 Dec, 18 | 14,036,847 | -8.76% |
| 30 Sep, 18 | 15,383,843 | 0.18% |
| 30 Jun, 18 | 15,356,289 | -2.75% |
| 31 Mar, 18 | 15,789,932 | -1.07% |
| 31 Dec, 17 | 15,959,979 | 0.48% |
| 30 Sep, 17 | 15,883,170 | -16.41% |
| 30 Jun, 17 | 19,001,860 | 15.56% |
| 31 Mar, 17 | 16,442,718 | -0.08% |
| 31 Dec, 16 | 16,455,948 | -4.79% |
| 30 Sep, 16 | 17,283,523 | 0.09% |
| 30 Jun, 16 | 17,268,801 | 10.27% |
| 31 Mar, 16 | 15,660,200 | 5.00% |
| 31 Dec, 15 | 14,914,761 | -27.74% |
| 30 Sep, 15 | 20,641,200 | 54.16% |
| 30 Jun, 15 | 13,389,523 | 14.54% |
| 31 Mar, 15 | 11,689,865 | 27.01% |
| 31 Dec, 14 | 9,203,739 | 209.39% |
| 30 Sep, 14 | 2,974,827 | 70.74% |
| 30 Jun, 14 | 1,742,300 | -8.94% |
| 31 Mar, 14 | 1,913,300 | - |
Eagle Pharmaceuticals (EGRX) has 9.87M shares outstanding as of 30 Jun 24, down -5.60% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 75.40% | 1.18% |
| 31 Mar, 24 | 79.87% | 1.36% |
| 31 Dec, 23 | 76.56% | 1.22% |
| 30 Sep, 23 | 79.22% | 1.16% |
| 30 Jun, 23 | 82.51% | 1.01% |
| 31 Mar, 23 | 90.22% | 1.13% |
| 31 Dec, 22 | 89.36% | 1.17% |
| 30 Sep, 22 | 87.26% | 1.07% |
| 30 Jun, 22 | 90.44% | 1.16% |
| 31 Mar, 22 | 88.26% | 1.19% |
| 31 Dec, 21 | 86.29% | 1.05% |
| 30 Sep, 21 | 90.45% | 1.07% |
| 30 Jun, 21 | 91.92% | 1.06% |
| 31 Mar, 21 | 93.22% | 1.12% |
| 31 Dec, 20 | 91.30% | 1.07% |
| 30 Sep, 20 | 92.41% | 1.03% |
| 30 Jun, 20 | 94.91% | 1.01% |
| 31 Mar, 20 | 97.13% | 1.03% |
| 31 Dec, 19 | 96.97% | 1.04% |
| 30 Sep, 19 | 96.44% | 1.00% |
| 30 Jun, 19 | 98.06% | 1.06% |
| 31 Mar, 19 | 96.25% | 1.01% |
| 31 Dec, 18 | 97.70% | 0.93% |
| 30 Sep, 18 | 102.48% | 0.96% |
| 30 Jun, 18 | 103.21% | 0.91% |
| 31 Mar, 18 | 106.55% | 0.93% |
| 31 Dec, 17 | 107.18% | 0.96% |
| 30 Sep, 17 | 105.55% | 0.68% |
| 30 Jun, 17 | 124.85% | 1.08% |
| 31 Mar, 17 | 107.77% | 0.96% |
| 31 Dec, 16 | 105.94% | 0.86% |
| 30 Sep, 16 | 111.00% | 0.91% |
| 30 Jun, 16 | 110.44% | 1.10% |
| 31 Mar, 16 | 100.15% | 1.10% |
| 31 Dec, 15 | 95.62% | 0.55% |
| 30 Sep, 15 | 132.40% | 1.78% |
| 30 Jun, 15 | 86.12% | 1.28% |
| 31 Mar, 15 | 82.05% | 1.91% |
| 31 Dec, 14 | 65.59% | 14.57% |
| 30 Sep, 14 | 21.22% | 13.74% |
| 30 Jun, 14 | 12.43% | 2.67% |
| 31 Mar, 14 | 21.59% | - |
As of 30 Jun 24, Eagle Pharmaceuticals is held by 75.40% institutional shareholders, representing a 1.18% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 24 | -41.46% |
| 31 Mar, 24 | 41 | -36.92% |
| 31 Dec, 23 | 65 | 38.30% |
| 30 Sep, 23 | 47 | -16.07% |
| 30 Jun, 23 | 56 | -24.32% |
| 31 Mar, 23 | 74 | -7.50% |
| 31 Dec, 22 | 80 | -3.61% |
| 30 Sep, 22 | 83 | 23.88% |
| 30 Jun, 22 | 67 | -5.63% |
| 31 Mar, 22 | 71 | 2.90% |
| 31 Dec, 21 | 69 | 18.97% |
| 30 Sep, 21 | 58 | -12.12% |
| 30 Jun, 21 | 66 | -15.38% |
| 31 Mar, 21 | 78 | 18.18% |
| 31 Dec, 20 | 66 | -23.26% |
| 30 Sep, 20 | 86 | 19.44% |
| 30 Jun, 20 | 72 | -4.00% |
| 31 Mar, 20 | 75 | -1.32% |
| 31 Dec, 19 | 76 | 2.70% |
| 30 Sep, 19 | 74 | -14.94% |
| 30 Jun, 19 | 87 | 12.99% |
| 31 Mar, 19 | 77 | -20.62% |
| 31 Dec, 18 | 97 | -10.19% |
| 30 Sep, 18 | 108 | 20.00% |
| 30 Jun, 18 | 90 | 15.38% |
| 31 Mar, 18 | 78 | -10.34% |
| 31 Dec, 17 | 87 | -21.62% |
| 30 Sep, 17 | 111 | - |
| 30 Jun, 17 | 111 | 44.16% |
| 31 Mar, 17 | 77 | -2.53% |
| 31 Dec, 16 | 79 | -7.06% |
| 30 Sep, 16 | 85 | 16.44% |
| 30 Jun, 16 | 73 | 8.96% |
| 31 Mar, 16 | 67 | -15.19% |
| 31 Dec, 15 | 79 | 1.28% |
| 30 Sep, 15 | 78 | -13.33% |
| 30 Jun, 15 | 90 | 55.17% |
| 31 Mar, 15 | 58 | 241.18% |
| 31 Dec, 14 | 17 | 13.33% |
| 30 Sep, 14 | 15 | -11.76% |
| 30 Jun, 14 | 17 | -39.29% |
| 31 Mar, 14 | 28 | - |
24 institutional shareholders have increased their position in EGRX stock as of 30 Jun 24 compared to 41 in the previous quarter (a -41.46% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 42 | 16.67% |
| 31 Mar, 24 | 36 | 50.00% |
| 31 Dec, 23 | 24 | -48.94% |
| 30 Sep, 23 | 47 | -7.84% |
| 30 Jun, 23 | 51 | -19.05% |
| 31 Mar, 23 | 63 | 28.57% |
| 31 Dec, 22 | 49 | - |
| 30 Sep, 22 | 49 | -32.88% |
| 30 Jun, 22 | 73 | 12.31% |
| 31 Mar, 22 | 65 | -4.41% |
| 31 Dec, 21 | 68 | 9.68% |
| 30 Sep, 21 | 62 | 19.23% |
| 30 Jun, 21 | 52 | -1.89% |
| 31 Mar, 21 | 53 | -22.06% |
| 31 Dec, 20 | 68 | 19.30% |
| 30 Sep, 20 | 57 | -16.18% |
| 30 Jun, 20 | 68 | 9.68% |
| 31 Mar, 20 | 62 | -12.68% |
| 31 Dec, 19 | 71 | -2.74% |
| 30 Sep, 19 | 73 | 35.19% |
| 30 Jun, 19 | 54 | -10.00% |
| 31 Mar, 19 | 60 | 15.38% |
| 31 Dec, 18 | 52 | 20.93% |
| 30 Sep, 18 | 43 | -25.86% |
| 30 Jun, 18 | 58 | -6.45% |
| 31 Mar, 18 | 62 | 12.73% |
| 31 Dec, 17 | 55 | 37.50% |
| 30 Sep, 17 | 40 | -11.11% |
| 30 Jun, 17 | 45 | -10.00% |
| 31 Mar, 17 | 50 | 4.17% |
| 31 Dec, 16 | 48 | 29.73% |
| 30 Sep, 16 | 37 | 32.14% |
| 30 Jun, 16 | 28 | -17.65% |
| 31 Mar, 16 | 34 | -12.82% |
| 31 Dec, 15 | 39 | 14.71% |
| 30 Sep, 15 | 34 | 30.77% |
| 30 Jun, 15 | 26 | 225.00% |
| 31 Mar, 15 | 8 | 33.33% |
| 31 Dec, 14 | 6 | 50.00% |
| 30 Sep, 14 | 4 | -33.33% |
| 30 Jun, 14 | 6 | - |
| 31 Mar, 14 | - | - |
42 institutional shareholders have reduced their position in EGRX stock as of 30 Jun 24 compared to 36 in the previous quarter (a 16.67% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 76 | -18.28% | 9,870,425 | -5.60% | 75.40% | 1.18% | 24 | -41.46% | 42 | 16.67% |
| 31 Mar, 24 | 93 | -12.26% | 10,455,770 | 4.33% | 79.87% | 1.36% | 41 | -36.92% | 36 | 50.00% |
| 31 Dec, 23 | 106 | -2.75% | 10,021,957 | -3.36% | 76.56% | 1.22% | 65 | 38.30% | 24 | -48.94% |
| 30 Sep, 23 | 109 | -13.49% | 10,370,529 | -3.75% | 79.22% | 1.16% | 47 | -16.07% | 47 | -7.84% |
| 30 Jun, 23 | 126 | -18.71% | 10,774,946 | -8.55% | 82.51% | 1.01% | 56 | -24.32% | 51 | -19.05% |
| 31 Mar, 23 | 155 | - | 11,782,592 | 1.94% | 90.22% | 1.13% | 74 | -7.50% | 63 | 28.57% |
| 31 Dec, 22 | 155 | 2.65% | 11,558,213 | 0.59% | 89.36% | 1.17% | 80 | -3.61% | 49 | - |
| 30 Sep, 22 | 151 | -6.79% | 11,489,984 | -1.02% | 87.26% | 1.07% | 83 | 23.88% | 49 | -32.88% |
| 30 Jun, 22 | 162 | 0.62% | 11,608,832 | 3.48% | 90.44% | 1.16% | 67 | -5.63% | 73 | 12.31% |
| 31 Mar, 22 | 161 | -1.83% | 11,218,296 | -0.39% | 88.26% | 1.19% | 71 | 2.90% | 65 | -4.41% |
| 31 Dec, 21 | 164 | 6.49% | 11,262,332 | -4.78% | 86.29% | 1.05% | 69 | 18.97% | 68 | 9.68% |
| 30 Sep, 21 | 154 | 6.94% | 11,827,798 | -1.84% | 90.45% | 1.07% | 58 | -12.12% | 62 | 19.23% |
| 30 Jun, 21 | 144 | -6.49% | 12,049,528 | -1.09% | 91.92% | 1.06% | 66 | -15.38% | 52 | -1.89% |
| 31 Mar, 21 | 154 | -4.94% | 12,182,835 | -1.03% | 93.22% | 1.12% | 78 | 18.18% | 53 | -22.06% |
| 31 Dec, 20 | 162 | -4.14% | 12,309,266 | -1.56% | 91.30% | 1.07% | 66 | -23.26% | 68 | 19.30% |
| 30 Sep, 20 | 169 | 4.32% | 12,504,305 | -3.59% | 92.41% | 1.03% | 86 | 19.44% | 57 | -16.18% |
| 30 Jun, 20 | 162 | -4.14% | 12,969,419 | -2.31% | 94.91% | 1.01% | 72 | -4.00% | 68 | 9.68% |
| 31 Mar, 20 | 169 | -7.65% | 13,275,943 | 0.33% | 97.13% | 1.03% | 75 | -1.32% | 62 | -12.68% |
| 31 Dec, 19 | 183 | -2.14% | 13,231,987 | 0.38% | 96.97% | 1.04% | 76 | 2.70% | 71 | -2.74% |
| 30 Sep, 19 | 187 | 0.54% | 13,181,490 | -2.47% | 96.44% | 1.00% | 74 | -14.94% | 73 | 35.19% |
| 30 Jun, 19 | 186 | -2.11% | 13,515,159 | 0.84% | 98.06% | 1.06% | 87 | 12.99% | 54 | -10.00% |
| 31 Mar, 19 | 190 | 2.15% | 13,403,180 | -4.51% | 96.25% | 1.01% | 77 | -20.62% | 60 | 15.38% |
| 31 Dec, 18 | 186 | -5.58% | 14,036,847 | -8.76% | 97.70% | 0.93% | 97 | -10.19% | 52 | 20.93% |
| 30 Sep, 18 | 197 | 3.68% | 15,383,843 | 0.18% | 102.48% | 0.96% | 108 | 20.00% | 43 | -25.86% |
| 30 Jun, 18 | 190 | 5.56% | 15,356,289 | -2.75% | 103.21% | 0.91% | 90 | 15.38% | 58 | -6.45% |
| 31 Mar, 18 | 180 | 0.56% | 15,789,932 | -1.07% | 106.55% | 0.93% | 78 | -10.34% | 62 | 12.73% |
| 31 Dec, 17 | 179 | -1.65% | 15,959,979 | 0.48% | 107.18% | 0.96% | 87 | -21.62% | 55 | 37.50% |
| 30 Sep, 17 | 182 | -0.55% | 15,883,170 | -16.41% | 105.55% | 0.68% | 111 | - | 40 | -11.11% |
| 30 Jun, 17 | 183 | 18.83% | 19,001,860 | 15.56% | 124.85% | 1.08% | 111 | 44.16% | 45 | -10.00% |
| 31 Mar, 17 | 154 | -3.14% | 16,442,718 | -0.08% | 107.77% | 0.96% | 77 | -2.53% | 50 | 4.17% |
| 31 Dec, 16 | 159 | 6.00% | 16,455,948 | -4.79% | 105.94% | 0.86% | 79 | -7.06% | 48 | 29.73% |
| 30 Sep, 16 | 150 | 14.50% | 17,283,523 | 0.09% | 111.00% | 0.91% | 85 | 16.44% | 37 | 32.14% |
| 30 Jun, 16 | 131 | -3.68% | 17,268,801 | 10.27% | 110.44% | 1.10% | 73 | 8.96% | 28 | -17.65% |
| 31 Mar, 16 | 136 | -5.56% | 15,660,200 | 5.00% | 100.15% | 1.10% | 67 | -15.19% | 34 | -12.82% |
| 31 Dec, 15 | 144 | 13.39% | 14,914,761 | -27.74% | 95.62% | 0.55% | 79 | 1.28% | 39 | 14.71% |
| 30 Sep, 15 | 127 | 3.25% | 20,641,200 | 54.16% | 132.40% | 1.78% | 78 | -13.33% | 34 | 30.77% |
| 30 Jun, 15 | 123 | 80.88% | 13,389,523 | 14.54% | 86.12% | 1.28% | 90 | 55.17% | 26 | 225.00% |
| 31 Mar, 15 | 68 | 142.86% | 11,689,865 | 27.01% | 82.05% | 1.91% | 58 | 241.18% | 8 | 33.33% |
| 31 Dec, 14 | 28 | 7.69% | 9,203,739 | 209.39% | 65.59% | 14.57% | 17 | 13.33% | 6 | 50.00% |
| 30 Sep, 14 | 26 | -7.14% | 2,974,827 | 70.74% | 21.22% | 13.74% | 15 | -11.76% | 4 | -33.33% |
| 30 Jun, 14 | 28 | - | 1,742,300 | -8.94% | 12.43% | 2.67% | 17 | -39.29% | 6 | - |
| 31 Mar, 14 | 28 | - | 1,913,300 | - | 21.59% | - | 28 | - | - | - |
Eagle Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Eagle Pharmaceuticals's stock was made by Tarriff Scott on Mar 01 2024, selling 2,119 shares at $6.27 per share (valued at $13.29K).
Eagle Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 2 | 6 | 33.33% |
| Q4 2023 | 2 | 7 | 28.57% |
| Q2 2023 | - | 6 | - |
| Q1 2023 | 8 | 7 | 114.29% |
| Q4 2022 | - | 1 | - |
| Q3 2022 | - | 1 | - |
| Q1 2022 | 9 | 8 | 112.50% |
| Q4 2021 | - | 1 | - |
| Q3 2021 | - | 6 | - |
| Q2 2021 | 5 | 4 | 125.00% |
| Q1 2021 | 8 | 8 | 100.00% |
| Q4 2020 | 3 | 5 | 60.00% |
| Q1 2020 | 14 | 8 | 175.00% |
| Q4 2019 | 1 | 13 | 7.69% |
| Q3 2019 | - | 3 | - |
| Q2 2019 | - | 3 | - |
| Q1 2019 | 16 | 15 | 106.67% |
| Q2 2018 | 1 | 1 | 100.00% |
| Q1 2018 | 22 | 4 | 550.00% |
| Q4 2017 | 1 | 1 | 100.00% |
2 total buy trades, and 6 total sell trades (buy/sell ratio of 0.33%) were made by Eagle Pharmaceuticals's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | - | - |
| Q4 2023 | - | 5 | - |
| Q2 2023 | - | 6 | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 1 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | 13 | - |
| Q3 2019 | - | 3 | - |
| Q2 2019 | - | 3 | - |
| Q1 2019 | - | 9 | - |
| Q2 2018 | - | - | - |
| Q1 2018 | - | 1 | - |
| Q4 2017 | - | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Eagle Pharmaceuticals's stocks.
Eagle Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| ANIP | ANI Pharmaceuticals, Inc. |
| PAHC | Phibro Animal Health Corporation |
| RGC | Regencell Bioscience Holdings Limited |
| SSIC | Silver Spike Investment Corp. |
| DCPH | Deciphera Pharmaceuticals, Inc. |
| PBH | Prestige Consumer Healthcare Inc. |
| ALKS | Alkermes plc |
| COLL | Collegium Pharmaceutical, Inc. |
| EOLS | Evolus, Inc. |
| AMPH | Amphastar Pharmaceuticals, Inc. |
EGRX Ownership FAQ
Who Owns Eagle Pharmaceuticals?
Eagle Pharmaceuticals is owned by institutional shareholders (75.40%), insiders (12.02%), and public (12.58%). The largest institutional shareholder of Eagle Pharmaceuticals is NANTAHALA CAPITAL MANAGEMENT, LLC (14.99% of total shares) and the top mutual fund owner is EntrepreneurShares Series Trust (0.09% of total shares).
Who are the major institutional shareholders of Eagle Pharmaceuticals?
Eagle Pharmaceuticals's major institutional shareholders are NANTAHALA CAPITAL MANAGEMENT, LLC, AIGH CAPITAL MANAGEMENT LLC, NANTAHALA CAPITAL MANAGEMENT, LLC, AQR CAPITAL MANAGEMENT LLC, and VANGUARD GROUP INC. The top five shareholders own together 41.52% of the company's share outstanding.
How many Eagle Pharmaceuticals shareholders are there?
As of Jun 2024, there are 76 institutional shareholders of Eagle Pharmaceuticals.
What percentage of Eagle Pharmaceuticals is owned by NANTAHALA CAPITAL MANAGEMENT, LLC?
NANTAHALA CAPITAL MANAGEMENT, LLC owns 1.96M shares of Eagle Pharmaceuticals, representing 14.99% of the company's total shares outstanding, valued at $10.99M (as of Jun 2024).
What percentage of Eagle Pharmaceuticals is owned by AIGH CAPITAL MANAGEMENT LLC?
As of Jun 2024, AIGH CAPITAL MANAGEMENT LLC holds 1.21M shares of Eagle Pharmaceuticals (EGRX), compromising 9.25% of the company, valued at $6.78M.
What percentage of Eagle Pharmaceuticals is owned by NANTAHALA CAPITAL MANAGEMENT, LLC?
NANTAHALA CAPITAL MANAGEMENT, LLC is the third largest holder of Eagle Pharmaceuticals. The company owns 1M of the company's shares outstanding (worth $5.6M).